Related Experiment Videos
Parkinson's disease: a broken nosology
1Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA. hardyj@mail.nih.gov
Summary
Defining Parkinson's disease (PD) pathologically requires Lewy bodies and specific substantia nigra loss. Alpha-synuclein gene mutations are the sole known cause, though their effects extend beyond PD to Lewy body dementia.
Area of Science:
- Neurology
- Pathology
- Genetics
Background:
- Parkinson's disease (PD) is currently diagnosed clinically.
- Progress in understanding PD pathogenesis is hindered by the lack of a precise pathological definition.
- Existing definitions may not fully capture the spectrum of alpha-synucleinopathies.
Purpose of the Study:
- To propose a pathological definition for Parkinson's disease.
- To identify the definitive cause of PD based on this pathological definition.
- To clarify the relationship between genetic causes and clinical phenotypes in alpha-synucleinopathies.
Main Methods:
- Review of existing literature on PD diagnosis and pathogenesis.
- Analysis of pathological hallmarks including Lewy bodies and nigral degeneration.
- Examination of genetic causes, specifically alpha-synuclein gene mutations.
Main Results:
- A pathological definition for PD requires Lewy bodies and nigral loss in the ventrolateral substantia nigra.
- Mutations in the alpha-synuclein gene are identified as the sole definitive cause of PD under this definition.
- The phenotype associated with alpha-synuclein gene mutations is broader than PD, including Lewy body dementia.
Conclusions:
- A precise pathological definition is crucial for advancing Parkinson's disease research.
- Alpha-synuclein gene mutations represent a key genetic driver of PD and related disorders.
- The spectrum of alpha-synucleinopathies necessitates a broader clinical and pathological perspective.